Aryl sulfonamides useful as inhibitors of chemokine receptor...

Details Aryl sulfonamides useful as inhibitors of chemokine receptor... Aryl sulfonamides useful as inhibitors of chemokine receptor...

2008-08-27

2011-11-22

Seaman, D (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S163000, C514S312000

Reexamination Certificate

active

08063222

ABSTRACT:
The present invention provides compounds of general formula I:or a pharmaceutically acceptable salt thereof, wherein R1, X, Z, R2, X1, Ar, n, R3and R4are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR8 and accordingly are useful for the treatment of a variety of inflammatory and allergic disorders.

REFERENCES:
patent: 5281626 (1994-01-01), Oinuma et al.
patent: 5354904 (1994-10-01), Mayer et al.
patent: 5378715 (1995-01-01), Stein et al.
patent: 5530118 (1996-06-01), Oinuma et al.
patent: 5571898 (1996-11-01), Schloesser et al.
patent: 5663414 (1997-09-01), Oinuma et al.
patent: 5994398 (1999-11-01), John et al.
patent: 6262112 (2001-07-01), Mittendorf et al.
patent: 6417181 (2002-07-01), Bender et al.
patent: 7855220 (2010-12-01), Neubert et al.
patent: 2003/0130287 (2003-07-01), Ackermann et al.
patent: 2004/0209948 (2004-10-01), Guan et al.
patent: 2004/0224978 (2004-11-01), Dai et al.
patent: 858 551 (1952-12-01), None
patent: 100 00 739 (2001-07-01), None
patent: 100 53 796 (2002-05-01), None
patent: 0 618 223 (1994-10-01), None
patent: 1 038 868 (2000-09-01), None
patent: 32002219 (1957-04-01), None
patent: 32005169 (1957-07-01), None
patent: 32008075 (1957-09-01), None
patent: 32008422 (1957-09-01), None
patent: 32009570 (1957-11-01), None
patent: 33007538 (1958-08-01), None
patent: 63017870 (1988-01-01), None
patent: 63208042 (1988-08-01), None
patent: 2051146 (1995-12-01), None
patent: 2051147 (1995-12-01), None
patent: 2053226 (1996-01-01), None
patent: 402606 (2000-08-01), None
patent: WO 91/12237 (1991-08-01), None
patent: WO 95/26957 (1995-10-01), None
patent: WO 96/40641 (1996-12-01), None
patent: WO 97/20822 (1997-06-01), None
patent: WO 99/29670 (1999-06-01), None
patent: WO 99/37609 (1999-07-01), None
patent: WO 99/62885 (1999-12-01), None
patent: WO 01/07403 (2001-02-01), None
patent: WO 01/58484 (2001-08-01), None
patent: WO 02/072549 (2002-09-01), None
patent: WO 2006/107252 (2006-10-01), None
patent: WO 2006/107253 (2006-10-01), None
patent: WO 2006/107254 (2006-10-01), None
patent: WO 2007/030061 (2007-03-01), None
Campos, Kevin R., et al., “Asymmetric synthesis of a prostaglandin D2 receptor antagonist,”Journal of Organic Chemistry, vol. 70 (2005) pp. 268-274.
Jenkins, Tracy J., et al., “Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8,”Journal of Medicinal Chemistry, vol. 50, No. 3 (2007) pp. 566-584.
Jin, Jian, et al., “Oxazolidinones as novel human CCR8 antagonists,”Bioorganic&Medicinal Chemistry Letters, vol. 17 (2007) pp. 1722-1725.
International Search Report dated Jun. 9, 2004 from corresponding PCT Application No. PCT/US03/41360.
Trushkin, et al., “ANSA-analysis. II. Aminonaphthalenesulfonamides as detectable groups for polysubstrate analysis of proteases,”Biokhimiya(Moscow) 59(10): 1521-1534 (1994).
Nedospasov, A. A., et al., “The Synthesis of N(S)-alkoxyethyl-substituted aminoaphthalenesulfonamides by opening an aziridene ring,”Synlett(8): 661-662 (1992).
Horstmann, H., et al., “Compounds With Schistosomicide Activity. 1. N4-(N-acyl-N-alkylglycyl)sulfanilamide,”European J. of Medicinal Chem., 12(4): 387-392 (1977).
Database Chemcats ′Online!, Chemical Abstracts Service, Columbus, Ohio, US; XP002280062, Order No. 5242677, 5242739, 5242752 & “Chembridge Product List” Jan. 17, 2002, Chembridge Corporation, 16981 Via Tazon, Suite G, San Diego, CA 92127, USA.
Database Chemcats ′Online!, Chemical Abstracts Service, Columbus, Ohio, US; XP002280063, Order No. BAS 0371287 & Interchim Intermediates, Jul. 9, 2002, Interchim, 213 Avenue Kennedy, BP 1140, Montlucon, Cedex, 03103, France.
Data Slides 1-15. Information was presented internally at Millennium Pharmaceuticals, Inc. Cambridge, MA, approximately Jul. 2005.

Affiliated with

Also associated with

Rating

Aryl sulfonamides useful as inhibitors of chemokine receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl sulfonamides useful as inhibitors of chemokine receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl sulfonamides useful as inhibitors of chemokine receptor... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4312160